METHYSDx Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $1.05M

  • Investors
  • 4

METHYSDx General Information

Description

Developer of an innovative diagnostic testing technology designed for cancer monitoring and prognosis. The company develops diagnostic kits based on proprietary methylation signatures and liquid biopsy technology, enabling healthcare professionals to analyze circulating tumor DNA and monitor disease progression in patients with advanced cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 67 rue Saint Jacques
  • 75005 Paris
  • France
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Corporate Office
  • 67 rue Saint Jacques
  • 75005 Paris
  • France

METHYSDx Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

METHYSDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Equity Crowdfunding 13-May-2026 $1.05M Completed Generating Revenue
6. Early Stage VC 01-Apr-2026 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
3. Seed Round 25-Aug-2023 Completed Startup
2. Accelerator/Incubator 16-Nov-2022 Completed Startup
1. Accelerator/Incubator 01-May-2021 Completed Startup
To view METHYSDx’s complete valuation and funding history, request access »

METHYSDx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view METHYSDx’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

METHYSDx Patents

METHYSDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026215463-A1 Detection of hypermethylated genes for diagnosing or monitoring urothelial cancer Pending 11-Apr-2025
WO-2026162840-A1 Detection of hypermethylated genes or genomic regions for diagnosing or monitoring sarcoma Pending 03-Feb-2025
EP-4735641-A1 Detection of hypermethylated genes for diagnosing colorectal cancer Pending 30-Jun-2023
WO-2025003512-A1 Detection of hypermethylated genes for diagnosing colorectal cancer Inactive 30-Jun-2023 C12Q1/6886

METHYSDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

METHYSDx Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Creative Destruction Lab Accelerator/Incubator
Neighborhood Accelerator/Incubator
Wilco(Paris) Accelerator/Incubator
Erganeo Venture Capital Minority
To view METHYSDx’s complete investors history, request access »

METHYSDx FAQs

  • When was METHYSDx founded?

    METHYSDx was founded in 2021.

  • Where is METHYSDx headquartered?

    METHYSDx is headquartered in Paris, France.

  • What is the size of METHYSDx?

    METHYSDx has 23 total employees.

  • What industry is METHYSDx in?

    METHYSDx’s primary industry is Diagnostic Equipment.

  • Is METHYSDx a private or public company?

    METHYSDx is a Private company.

  • What is the current valuation of METHYSDx?

    The current valuation of METHYSDx is .

  • What is METHYSDx’s current revenue?

    The current revenue for METHYSDx is .

  • How much funding has METHYSDx raised over time?

    METHYSDx has raised $2.72M.

  • Who are METHYSDx’s investors?

    Creative Destruction Lab, Neighborhood, Wilco(Paris), and Erganeo have invested in METHYSDx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process